CADL R&D Expenses

Candel Therapeutics Inc · R&D Expenses

CADL logo

CADL R&D Expenses

Latest reported$19.80M
CADL Quarterly R&D Expenses ($1.62M → $19.80M)
High-resolution chart · PNG

CADL r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Candel Therapeutics Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
19,801,000
9,840,000
11,028,000
8,461,000
6,991,000
4,016,000
4,817,000
5,416,000
4,979,000
4,102,000
7,258,000
5,845,000
5,934,000
5,469,000
4,696,000
5,376,000
5,022,000
5,417,000
3,676,000
5,265,000
3,292,000
2,753,000
3,534,000
1,813,000
1,795,000
1,621,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.